Evidence map›Paper›PMID 40459659›Full record

ReviewInternational journal of clinical oncology2025

Palliative radiotherapy for painful non-bone-metastasis tumors.

Tetsuo Saito

Abstract readReview
PubMed Publisher
In one paragraph

Review in International journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tetsuo SaitoDivision of Integrative Medical Oncology, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Minami-Ku, Kumamoto-Shi, Kumamoto, 861-4193, Japan. tetsuosaito1977@gmail.com.ORCID http://orcid.org/0000-0003-1955-6773

Funding

JSPS KAKENHI (24K10764)
6 · The paper itself

Abstract

As suggested by the findings of our previous investigations, palliative radiotherapy for painful lesions other than bone metastases may be as commonly used in clinical settings as it is for painful bone metastases (PBMs). Given the substantial number of patients requiring radiotherapy for painful non-bone-metastasis tumors (PNTs), the absence of specific clinical guidelines for this subset of patients poses a significant issue. This review aims to explore the effectiveness of palliative radiotherapy for PNTs and compare it to the well-established evidence supporting its use for PBMs. Additionally, the review discusses the optimal dose-fractionation schedules in palliative radiotherapy for the management of PNTs.

Indexed as

Cancer PainNeoplasmsPalliative CareBone NeoplasmsDose Fractionation, RadiationHumansNeoplasm MetastasisPainful bone metastasesPainful non-bone-metastasis tumorsPain interferencePain responsePalliative radiotherapy

Identifiers

PMID40459659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.